{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:26:56Z","timestamp":1790130416145,"version":"4.0.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515010694"],"award-info":[{"award-number":["2019A1515010694"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011546"],"award-info":[{"award-number":["2019A1515011546"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> This study aimed to summarize the clinicopathological features and prognostic risk factors of primary antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in children.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Clinical and prognostic data for children admitted to our center with AAV between September 2003 and September 2020 were studied retrospectively. The incidence and risk factors of end-stage renal disease (ESRD) were calculated and analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Thirty-four children were enrolled; 28 were female, with a median onset age of 10 years. Except for one case negative for ANCA, the other 33 patients were diagnosed with microscopic polyangiitis (MPA). The most frequently involved organ was the kidney (100.0%), followed by the lungs (58.8%) and heart (50.0%). Twenty children (58.8%) progressed to ESRD with a median course of 3 months, and they were more likely to present respiratory and cardiovascular system involvement than were the non-ESRD group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Patients in the ESRD group also had a higher serum creatinine level, 24-h protein excretion, Pediatric Vasculitis Activity Score (PVAS), and a lower level of estimated glomerular filtration rate (eGFR), hemoglobin, and complement C3 than had those in the non-ESRD group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). The main pathological manifestations were crescentic and sclerotic classes in the ESRD group and focal class in the non-ESRD group. After 6 months of induction therapy, 90.0% of cases achieved complete or partial remission. The multivariate logistic regression model showed that baseline eGFR &amp;lt; 60 ml\/min\/1.73 m<jats:sup>2<\/jats:sup> was an independent risk factor for progressing to ESRD (<jats:italic>OR<\/jats:italic> = 0.016, 95% CI = 0.001~0.412, <jats:italic>P<\/jats:italic> = 0.012).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> AAV in children usually occurs in teenage girls, and the most commonly involved organ is the kidney, of which hematuria is the most common symptom, followed by proteinuria, abnormal renal function (eGFR &amp;lt; 90 ml\/min\/1.73 m<jats:sup>2<\/jats:sup>), etc. The primary type of AAV is MPA. Nearly 60% of patients progressed to ESRD with a median course of 3 months. Baseline eGFR &amp;lt; 60 ml\/min\/1.73 m<jats:sup>2<\/jats:sup> is an independent risk factor for ESRD progression in AAV children.<\/jats:p>","DOI":"10.3389\/fped.2021.656307","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T05:59:00Z","timestamp":1619416740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinicopathological Analysis of 34 Cases of Primary Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Chinese Children"],"prefix":"10.3389","volume":"9","author":[{"given":"Jingyi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0272-6386(12)80521-X","article-title":"Antineutrophil cytoplasmic autoantibodies and associated diseases: a review","volume":"15","author":"Jennette","year":"1990","journal-title":"Am. J. Kidney Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/01.ASN.0000016442.33680.3E","article-title":"ANCA-positive vasculitis","volume":"13","author":"Kamesh","year":"2002","journal-title":"J. Am. Soc. Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fped.2018.00226","article-title":"Primary vasculitis in childhood: GPA and MPA in childhood","volume":"6","author":"Jariwala","year":"2018","journal-title":"Front. Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cdtm.2018.05.004","article-title":"Antineutrophil cytoplasmic antibodies-associated glomerulonephritis: from bench to bedside","volume":"4","author":"Chen","year":"2018","journal-title":"Chronic Dis. Transl. Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1136\/annrheumdis-2012-202111","article-title":"Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)","volume":"72","author":"Dolezalova","year":"2013","journal-title":"Ann. Rheum. Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann. Rheum. Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00467-016-3490-6","article-title":"Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis","volume":"32","author":"Kouri","year":"2017","journal-title":"Pediatr. Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J. Am. Soc. Nephrol"},{"key":"B11","first-page":"85","article-title":"The utility of the ACR\/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"36","author":"Yoo","year":"2018","journal-title":"Clin. Exp. Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00467-012-2198-5","article-title":"ANCA-associated glomerulonephritis\/systemic vasculitis in childhood: clinical features-outcome","volume":"27","author":"Siomou","year":"2012","journal-title":"Pediatr. Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-3035","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1681\/ASN.2018010090","article-title":"A new criterion for pediatric aki based on the reference change value of serum creatinine","volume":"29","author":"Xu","year":"2018","journal-title":"J. Am. Soc. Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","article-title":"Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis","volume":"2","author":"Cattran","year":"2012","journal-title":"Kidney Int. Suppl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00467-016-3559-2","article-title":"Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management","volume":"33","author":"Plumb","year":"2018","journal-title":"Pediatr. Nephrol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/art.39122","article-title":"Brief report: childhood-onset systemic necrotizing vasculitides: long-term data from the French vasculitis study group registry","volume":"67","author":"Iudici","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ekir.2018.01.012","article-title":"Patient outcomes in renal-limited antineutrophil cytoplasmic antibody vasculitis with inactive histology","volume":"3","author":"Novick","year":"2018","journal-title":"Kidney Int. Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13052-017-0364-x","article-title":"ANCA-associated vasculitis in childhood: recent advances","volume":"43","author":"Calatroni","year":"2017","journal-title":"Ital. J. Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108325","DOI":"10.1016\/j.clim.2019.108325","article-title":"Childhood GPA, EGPA, and MPA","volume":"211","author":"Jariwala","year":"2020","journal-title":"Clin. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e158871","DOI":"10.1371\/journal.pone.0158871","article-title":"Low serum complement C3 levels at diagnosis of renal ANCA-associated vasculitis is associated with poor prognosis","volume":"11","author":"Augusto","year":"2016","journal-title":"Plos ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"102424","DOI":"10.1016\/j.autrev.2019.102424","article-title":"Complement alternative pathway in ANCA-associated vasculitis: two decades from bench to bedside","volume":"19","author":"Brilland","year":"2020","journal-title":"Autoimmun. Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.semnephrol.2017.05.016","article-title":"ANCA-associated vasculitis: pathogenesis, models, and preclinical testing","volume":"37","author":"Hutton","year":"2017","journal-title":"Semin. Nephrol"},{"key":"B26","first-page":"111","article-title":"Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis","volume":"35","author":"Yoo","year":"2017","journal-title":"Clin. Exp. Rheumatol"},{"key":"B27","first-page":"47","article-title":"Chest and renal involvements, Birmingham vascular activity score more than 13.5 and five factor score. (1996) more than 1 at diagnosis are significant predictors of relapse of microscopic polyangiitis.","volume":"35","author":"Oh","year":"2017","journal-title":"Clin. Exp. Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.semarthrit.2017.07.004","article-title":"The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: a study of 504 cases in a single Chinese center","volume":"47","author":"Bai","year":"2018","journal-title":"Semin. Arthritis. Rheum"},{"key":"B29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3349\/ymj.2018.59.3.397","article-title":"Delta neutrophil index is associated with vasculitis activity and risk of relapse in ANCA-associated vasculitis","volume":"59","author":"Yoo","year":"2018","journal-title":"Yonsei. Med. J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"106819","DOI":"10.1016\/j.intimp.2020.106819","article-title":"Clinical characteristics and prognostic risk factors of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV)","volume":"87","author":"Chen","year":"2020","journal-title":"Int. Immunopharmacol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/RHU.0000000000001456","article-title":"Thai patients with antineutrophil cytoplasmic antibody-associated vasculitis: outcomes and risk factors for mortality","author":"Intapiboon","year":"2020","journal-title":"J. Clin. Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3530768","DOI":"10.1155\/2020\/3530768","article-title":"Clinical characteristics of peripheral neuropathy in eosinophilic granulomatosis with polyangiitis: a retrospective single-center study in China","volume":"2020","author":"Zhang","year":"2020","journal-title":"J. Immunol. Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1093\/ndt\/gfr643","article-title":"Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center","volume":"27","author":"Chang","year":"2012","journal-title":"Nephrol. Dial. Transpl"},{"key":"B34","doi-asserted-by":"publisher","first-page":"916","DOI":"10.11817\/j.issn.1672-7347.2020.190436","article-title":"Clinical characteristics and prognosis in 269 patients with antineutrophil cytoplasimc antibody associated vasculitis","volume":"45","author":"Wu","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00467-014-2970-9","article-title":"Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients","volume":"30","author":"Khalighi","year":"2015","journal-title":"Pediatr. Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s00467-014-2885-5","article-title":"Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis","volume":"29","author":"Li","year":"2014","journal-title":"Pediatr. Nephrol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/ndt\/gfu237","article-title":"Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors","volume":"30","author":"Tanna","year":"2015","journal-title":"Nephrol. Dial. Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000479012","article-title":"Immunosuppressive treatment in C3 glomerulopathy: is it really effective?","volume":"46","author":"Caliskan","year":"2017","journal-title":"Am. J. Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","article-title":"C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy","volume":"93","author":"Bomback","year":"2018","journal-title":"Kidney Int"},{"key":"B40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10157-020-01925-5","article-title":"ANCA-associated nephritis without crescent formation has atypical clinicopathological features: a multicenter retrospective study","volume":"24","author":"Zoshima","year":"2020","journal-title":"Clin. Exp. Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00467-020-04799-72021","article-title":"Predictors of poor kidney outcome in children with C3 glomerulopathy","volume":"36","author":"Pinarba\u015fi","year":"2021","journal-title":"Pediatr. Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3899\/jrheum.150376","article-title":"CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides","volume":"43","author":"McGeoch","year":"2016","journal-title":"J. Rheumatol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.656307\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T05:59:07Z","timestamp":1619416747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.656307\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":42,"alternative-id":["10.3389\/fped.2021.656307"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.656307","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"article-number":"656307"}}